Tag | Content |
---|
EnhancerAtlas ID | HS059-02395 |
Organism | Homo sapiens |
Tissue/cell | GM12878 |
Coordinate | chr1:111716580-111717500 |
Target genes | Number: 16 | Name | Ensembl ID |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOS | MA0476.1 | chr1:111717245-111717256 | AATGAGTCAGA | - | 6.32 | MEF2C | MA0497.1 | chr1:111716666-111716681 | GTTCTCAAAATAGAA | + | 6.21 | MEOX2 | MA0706.1 | chr1:111717439-111717449 | AGTAATTAAC | + | 6.02 | TBX20 | MA0689.1 | chr1:111716989-111717000 | TTTCACACCTA | - | 6.14 | TBX2 | MA0688.1 | chr1:111716989-111717000 | TTTCACACCTA | - | 6.32 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_11520 | chr1:111707642-111752738 | CD20 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TTTAAATTAT GCTATTATAA ATTTATAATT CCATAGTGAA TAACCTTGTA CAAACATCAT 60 TTTGTGCAAG TATATCTGTA GGGTAAGTTC TCAAAATAGA AGGCATTTGA ATCCAGTAAT 120 CTAAGAATGA TAATCTCAAA ATTGTAGAAG GTGCTAAGTT TACAAGAGGA AAGGAAAAAC 180 AGCATATGTT TTGCTTCTCA ATCTTTTTGC CCATGTTCTT TTTTTTCACA CTTTCAGGCT 240 TCTAATTTCT GCTGCCCTGT TGTGCATGAG GTTTGTCTCT TCTTGACTGT AAAATTATTT 300 TCAGCAACCC CAAAGCTAAT TCTTGGCTGC TTTCAGTATC TTCTTTGCAG AAGTCTCAGA 360 GTAGTTAACC TAGTAAGAAT AGGAATTTGA GAACTGGAGG AGTTTTTTTT TTCACACCTA 420 TACAATGGCA GACATTAAAT GAATATATCT AAAGAACAGT AAGTTTTACA GAGTCTTAGT 480 GATTTATGTT AACTTTAATT AAAGCACACC ATTTATTTCA TCTGATACTA CAAAGCACTT 540 ATTTCAAGAT TTCATATTTT ATAACAGTGC AATGTAATCC TCTGCTTGAT ACTCAAAATT 600 TAATACCTCC TCAATTTTTT TTTTTTTTGG TGGGAAAGGT TAACCTATGG TTTCAGCCCA 660 ACTTCAATGA GTCAGAAATT TCCTTTGGAA AGGAGGGGTT TTTATTGCTC TTTGAAATTC 720 ATCAAATTAA ATTAAAAGGC TTTGGATTTT ATATGATTTT GCTCATAACA AATTTTTGAT 780 GCCTCCTTTT CCCCTTTCCT CAATATTTGA GATTTTTTTT TTCTATTGTG CATGATAGAG 840 GAATGCTGCT AAGCTTGCAA GTAATTAACT TGAAATTGTT GTGACTAATT CTGCTCTTTT 900 GGCTTTTTGT ACCTAATCAG 920
|